KORKMAZ, O. T. And Tuncel, N. 2018. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease. CURRENT PHARMACEUTICAL DESIGN , vol.24, no.39 , 4693-4701.

KORKMAZ, O. T., & Tuncel, N., (2018). Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease. CURRENT PHARMACEUTICAL DESIGN , vol.24, no.39, 4693-4701.

KORKMAZ, ORHAN, And Nese Tuncel. "Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease," CURRENT PHARMACEUTICAL DESIGN , vol.24, no.39, 4693-4701, 2018

KORKMAZ, ORHAN T. And Tuncel, Nese. "Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease." CURRENT PHARMACEUTICAL DESIGN , vol.24, no.39, pp.4693-4701, 2018

KORKMAZ, O. T. And Tuncel, N. (2018) . "Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease." CURRENT PHARMACEUTICAL DESIGN , vol.24, no.39, pp.4693-4701.

@article{article, author={ORHAN TANSEL KORKMAZ And author={Nese Tuncel}, title={Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease}, journal={CURRENT PHARMACEUTICAL DESIGN}, year=2018, pages={4693-4701} }